Publications
39
Citations
509
Est. group size
~3
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~5 · 26% small-team papers (≤3 authors) · across 18 venues
- A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024
Therapeutic Apheresis and Dialysis · 2026
- Metabolic complications of citrate anticoagulation in continuous renal replacement therapy (crrt): a delphi consensus on indications, monitoring and management
Critical Care · 2026
- Troubleshooting Ionized Hypocalcemia in Patients on Continuous KRT with Regional Citrate Anticoagulation
Kidney360 · 2025
- Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human
PLoS ONE · 2023
- Extracorporeal Immunomodulation Therapy in Acute Chronic Liver Failure With Multiorgan Failure: First in Human Use
ASAIO Journal · 2023
- Citrate Anticoagulation for CKRT with Liver Failure
Clinical Journal of the American Society of Nephrology · 2023
- Role of Immunomodulation Therapy with Selective Cytopheretic Device (SCD) in Reversing Acute on Chronic Liver Failure (ACLF) with Hepatorenal Syndrome (HRS) and Multi-Organ Failure
Journal of the American Society of Nephrology · 2023
- Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
Critical Care Explorations · 2022
- Translation of Immunomodulatory Therapy to Treat Chronic Heart Failure: Preclinical Studies to First in Human
medRxiv · 2022
- Management of dysnatremias with continuous renal replacement therapy
Seminars in Dialysis · 2021
- Regional citrate anticoagulation “non-shock” protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance
BMC Nephrology · 2021
- Citrate Anticoagulation for Continuous Kidney Replacement Therapy: An Embarrassment of RICH-es
American Journal of Kidney Diseases · 2021
- Technology Innovations in Continuous Kidney Replacement Therapy: The Clinician's Perspective
Advances in Chronic Kidney Disease · 2021
- 239: SCD TREATMENT IN COVID-19 ICU PATIENTS WITH ARDS AND AKI IS SAFE AND MAY IMPROVE OUTCOMES
Critical Care Medicine · 2021
- SCD Treatment in COVID-19 ICU Patients with ARDS and AKI Is Safe and May Improve Clinical Outcomes
Journal of the American Society of Nephrology · 2021
- ASAIO Journal×3
- Advances in Chronic Kidney Disease×2
- Kidney360×2
- Elsevier eBooks×2
- Journal of the American Society of Nephrology×2
- Michael Heung
Medicine · University of Michigan
- Danielle E. Soranno
Medicine · Indiana University
- Lenar Yessayan
Medicine · University of Michigan
- Stephen M. Gorga
Medicine · University of Michigan
- Cara Slagle
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile